The BMS-Pfizer Alliance is committed to supporting best practice and enhancing patient care within the NHS. As part of this commitment, this non-promotional training programme aimed to upskill GPs so that they can optimise the management of patients with cardiovascular disease in primary care. The potential benefits included improving the detection of heart failure and atrial fibrillation, as well as reducing stroke rates and hospital admissions.
The programme was offered to all Clinical Commissioning Groups (CCGs) in England. In 2017, the BMS-Pfizer Alliance supported 14 upskilling meetings across England.